XML 16 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash flows from operating activities:    
Net income (loss) $ 9,340,000 $ (613,926)
Adjustment to reconcile net income to net cash (used) provided by operating activities:    
Depreciation and amortization 607,528 333,087
Amortization of debt issuance costs and accretion of debt discount 6,467 5,722
Non-cash lease expense 4,042 (4,704)
Stock compensation expense 739,960 352,299
Earn-out fair value and write-off adjustments 407,071
Recognition and change in fair value of warrant liabilities (11,845,964)
Change in operating assets and liabilities:    
Accounts payables and other accrued liabilities (1,715,666) (893,505)
Accounts receivable (148,552) 181,556
Accounts receivable, related parties 5,489 (7,131)
Other receivables (7,336)
Other payables (1,467)
Charge back reserve 100,962  
Other non-current assets (52,992)
Prepaid expense and other current assets 2,217,178
Net cash used in operating activities (343,280) (646,602)
Cash flows from investing activities:    
Purchase of property and equipment (4,108)
Acquisition of business, net of cash acquired (18,138,750)
Purchase of intangibles (249,235)
Net cash used in investing activities (18,392,093)
Cash flows from financing activities:    
Principal repayments of debt (227,172) (213,994)
Proceeds from loans payable, related parties 177,824
Payments of loans payable, related parties (10,770) (310,771)
Proceeds from exercise of warrants into common stock 2,475,000
Net proceeds from private placement issuance of shares and warrants 17,853,351
Issuance of common stock 10,481,938
Net cash provided by financing activities 20,090,409 10,134,997
Net increase in cash and restricted cash 1,355,036 9,488,395
Cash and restricted cash at beginning of period 4,620,722 529,581
Cash and restricted cash at end of period   5,975,758 10,017,976
Supplemental disclosure of cash and non-cash investing and financing transactions:    
Issuance of Series D Warrants 6,930,335
Issuance of placement agent warrants 1,525,923
Conversion of common stock into Series C Warrants 281,815
Conversion of preferred stock into common stock 339,264
Cash paid for interest 105,447 116,830
Conversion of debt into equity 3,800,000
Common stock issued pursuant to acquisition 4,763,451
Common stock issued in lieu of services 91,050
Issuance of common stock pursuant to the purchase of software $ 340,000